2024年日本脓毒症与脓毒性休克管理临床实践指南
J-SSCG 2024由日本重症医学会与日本急诊医学会联合发布,是自2012年首版以来的第四次修订。指南覆盖脓毒症诊断与感染源控制、抗菌治疗、初始复苏、血液净化、弥散性血管内凝血、辅助治疗、重症后综合征、患者与家庭照护及儿科共九个领域,提取78个重要临床问题。采用GRADE方法制定推荐,并通过改良Delphi法由全体委员会成员投票确定推荐,最终形成42条GRADE推荐、7条良好实践声明和22条背景信息问答,另描述12个未来研究问题。
要点
- J-SSCG 2024由日本重症医学会与日本急诊医学会联合发布,为2012年首版以来第四次修订。
- 指南覆盖脓毒症诊断与感染源控制、抗菌治疗、初始复苏、血液净化、DIC、辅助治疗、PICS、患者与家庭照护及儿科共9个领域。
- 共提取78个重要临床问题,采用GRADE方法制定推荐,改良Delphi法由全体委员会成员投票确定推荐。
- 最终形成42条GRADE推荐、7条良好实践声明和22条背景信息问答,另描述12个未来研究问题。
- 指南目标读者包括识别脓毒症并提供初始管理的医师、接续治疗的专业医师以及护士、物理治疗师、临床工程师和药师等多学科团队。
适用人群与场景
- 识别脓毒症并提供初始管理的医师、接续治疗的专业医师以及包括护士、物理治疗师、临床工程师和药师在内的多学科医疗提供者。
研究设计与关键结果
- 制定机构为日本重症医学会与日本急诊医学会,采用GRADE方法制定推荐,并以改良Delphi法由全体委员会成员投票确定推荐。
- 指南覆盖9个领域:脓毒症诊断与感染源控制、抗菌治疗、初始复苏、血液净化、弥散性血管内凝血、辅助治疗、重症后综合征、患者与家庭照护、儿科。
- 共提取78个重要临床问题,形成42条GRADE推荐、7条良好实践声明和22条背景信息问答,另描述12个未来研究问题。
证据类型、等级与局限
- 证据类型:临床实践指南;推荐制定采用GRADE方法,推荐强度由改良Delphi法全体委员会成员投票确定。
- 局限:原文未报告局限性
对床旁实践的改变
- 原文未据此给出推荐
指南或共识出处
- Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024(J-SSCG 2024),日本重症医学会与日本急诊医学会发布,2024年。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
The 2024 revised edition of the Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock (J-SSCG 2024) is published by the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine. This is the fourth revision since the first edition was published in 2012. The purpose of the guidelines is to assist healthcare providers in making appropriate decisions in the treatment of sepsis and septic shock, leading to improved patient outcomes. We aimed to create guidelines that are easy to understand and use for physicians who recognize sepsis and provide initial management, specialized physicians who take over the treatment, and multidisciplinary healthcare providers, including nurses, physical therapists, clinical engineers, and pharmacists. The J-SSCG 2024 covers the following nine areas: diagnosis of sepsis and source control, antimicrobial therapy, initial resuscitation, blood purification, disseminated intravascular coagulation, adjunctive therapy, post-intensive care syndrome, patient and family care, and pediatrics. In these areas, we extracted 78 important clinical issues. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) method was adopted for making recommendations, and the modified Delphi method was used to determine recommendations by voting from all committee members. As a result, 42 GRADE-based recommendations, 7 good practice statements, and 22 information-to-background questions were created as responses to clinical questions. We also described 12 future research questions.
参考来源
- Shime N, Nakada TA, Yatabe T, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2024. J Intensive Care. 2025. PMID: 40087807. doi:10.1186/s40560-025-00776-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。